Article

Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients

2022-04-13

Abstract excerpt

<h4>Summary</h4> <h4>Importance</h4> Drug repurposing requires distinguishing established drug class targets from novel molecule-specific mechanisms and rapidly derisking their therapeutic potential in a time-critical manner, particularly in a pandemic scenario. In response to the challenge to rapidly identify treatment options for COVID-19, several studies reported that statins, as a drug class, reduce mortality...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: feeb8661-9cc5-58cf-868d-08e124234d81
DOI: 10.1101/2022.04.12.22273802

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsDOI 10.1101/2022.04.12.22273802Read

Ontological and Bioinformatic Analysis of Anti-Coronavirus Drugs and Their Implication for Drug Repurposing against COVID-19Semantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Host - virus - drug interactions as determinants of COVID-19's phenotypes: A data-driven hypothesis.Semantic proximity Read

Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

SPLIT: Safety Prioritization for Long COVID Drug Repurposing via a Causal Integrated Targeting FrameworkSemantic proximity Read

Rapid Identification of Druggable Targets and the Power of the Phenotype SIMulator for Effective Drug Repurposing in COVID-19Semantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

Identification of pulmonary comorbid diseases network based repurposing effective drugs for COVID-19Semantic proximity Read

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity Read

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSSemantic proximity Read